The Use of Systemic Medications in Psoriasis

Dr. Tina Bhutani is a board certified dermatologist and clinical researcher practicing in San Francisco, California. She received her medical training at the University of Southern California Keck School of Medicine and completed her residency in dermatology at UCSF. Dr. Bhutani has an expertise in the treatment of psoriasis, atopic dermatitis, and other inflammatory skin diseases. In addition to seeing patients, she is a Associate Adjunct Professor in the Department of Dermatology at UCSF. She is passionate about improving the care and lives of patients with inflammatory skin disorders and is involved in many studies focusing on the development of new treatments for these diseases and learning more about mechanisms of disease initiation and maintenance. She has a particular interest in the impact of disease on patient quality of life and mental health as well as the use of wellness-based behavior modification to improve disease severity and reduce the risk of associated comorbidities. She has published over 150 articles in peer-reviewed journals and has spoken at national and international conferences on these topics. She is a member of the National Psoriasis Foundation (NPF) Scientific Advisory committee and has received research grant funding from the NPF, the Dermatology Foundation, as well as Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). She also serves as the current editor-in-chief for the journal Psoriasis: Targets and Therapy. 

Dr. Hawkes is a board-certified dermatologist and Investigator at the Oregon Medical Research Center in Portland, Oregon. He completed his medical school and residency at the University of Utah. During medical school, he completed a fellowship in translational immunology in the NIH-HHMI Research Scholars Program. He also received a Master’s Degree in Clinical Investigation from Rockefeller University, where he was Chief Clinical Scholar and Principal and sub-Investigator on multiple human research protocols in the Laboratory for Investigative Dermatology. He has held academic appointments in the Departments of Dermatology at the University of Utah, University of California-Davis, Icahn School of Medicine at Mount Sinai.

Dr. Hawkes is a current Councilor in the International Psoriasis Council and serves on the NPF Medical Board and Scientific Advisory Committee. He also serves as the official delegate of the AAD as a member of the international guidelines and workgroup committee for urticaria. His research has been funded by the NIH, NSF, NPF, and Dermatology Foundation, and he is the recipient of several teaching awards including NPF Outstanding Educator in Psoriatic Disease and Exceptional Teacher of the Year in the Department of Dermatology at Mount Sinai. His primary clinical and research interests include novel immune therapies for inflammatory conditions like psoriasis, atopic dermatitis, HS, alopecia areata, vitiligo, and urticaria.